KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Novartis Ag (NVS) over the last 14 years, with Q4 2025 value amounting to $155.0 million.

  • Novartis Ag's Short-term Investments fell 9224.22% to $155.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $155.0 million, marking a year-over-year decrease of 9224.22%. This contributed to the annual value of $155.0 million for FY2025, which is 9224.22% down from last year.
  • Novartis Ag's Short-term Investments amounted to $155.0 million in Q4 2025, which was down 9224.22% from $344.0 million recorded in Q2 2025.
  • In the past 5 years, Novartis Ag's Short-term Investments registered a high of $16.1 billion during Q2 2022, and its lowest value of $130.0 million during Q1 2025.
  • For the 5-year period, Novartis Ag's Short-term Investments averaged around $3.5 billion, with its median value being $411.0 million (2024).
  • Its Short-term Investments has fluctuated over the past 5 years, first surged by 665020.92% in 2022, then crashed by 9820.86% in 2023.
  • Novartis Ag's Short-term Investments (Quarter) stood at $15.9 billion in 2021, then decreased by 28.32% to $11.4 billion in 2022, then tumbled by 90.93% to $1.0 billion in 2023, then soared by 93.04% to $2.0 billion in 2024, then plummeted by 92.24% to $155.0 million in 2025.
  • Its Short-term Investments stands at $155.0 million for Q4 2025, versus $344.0 million for Q2 2025 and $130.0 million for Q1 2025.